Description
The Beacon® single-cell optofluidic system combines a unique optoelectro positioning (OEP) technology with novel microfluidic technology. It can be used to accurately select single cells on a chip, perform multiple single-cell assays, and export target cells based on specific results. The Beacon® optofluidic platform preserves the diversity of B cells, generating high-quality positive hits at an early stage of discovery and avoiding the loss of “good clones”.
Advantage:
• 1 day: Complete all B cell sorting in one day
• >10,000 cells: Screen more than 10,000 B cells at one time
• 35 days: Obtain positive clones within 35 days at the earliest
• 3–4 rounds: Three to four rounds of forward supernatant screening